EFSA published on 17.03.2023 the agendas for the Peer Review Experts’ Meetings for April 2023.
19th March 2023
Agenda Expert meetings April 2023 published
19March
9th June 2022
Public Consultation on phenmedipham ED assessment
09June
On 08.06.2022 EFSA opened a public consultation on the revised RAR for phenmedipham, and the assessments following the stop-the-clock for endocrine disruption properties.
17th May 2022
Extension 50 substances published
17May
An implementing Regulation was published on 10.05.2022, extending the approval periods of ca. 50 substances.
14th March 2022
Agenda SCoPAFF Legislation 30-31 March published
14March
On 14.03.2022 the agenda for the SCoPAFF Legislation meeting of 30-31.03.2022 was published on the DG SANTE website.
11th June 2021
Agenda SCoPAFF Residues meeting June 2021
11June
The agenda for the SCoPAFF Residues meeting on 14-15 June was published on the renewed website of DG SANTE.
11th May 2021
Approval periods of 44 substances extended
11May
On 07.05.2020 the extension of 44 substances was published in the Official Journal.
22nd March 2021
SCoPAFF B- & C-Documents published
22March
Several documents for the B- and C-points on the agenda of the SCoPAFF Legislation meeting of 24-25 March 2021 were uploaded to the Comitology Register.
8th March 2021
Agenda SCoPAFF Legislation 24-25 March published
08March
The agenda for the upcoming SCoPAFF Legislation meeting was published on the Commission website.
2nd March 2021
EFSA opinion MRL phenmedipham strawberries
02March
EFSA published on 26.02.2021 a reasoned opinion on modifying the MRL for phenmedipham on strawberries.
22nd October 2020
RoQ 21.10.2020
22October
acibenzolar-s-methyl, phenmedipham, Trichoderma atroviride AGR2
11th August 2020
RoQ 10.08.2020
11August
azoxystrobin, dodine, ethiprole, mancozeb, oxamyl, phenmedipham
31st July 2020
Minutes SCoPAFF Legislation May
31July
On 29.07.2020 the minutes of the SCoPAFF Legislation meeting of 18-19 May were published.
26th June 2020
Approval extensions published
26June
on 25.06.2020 a Regulation was published, extending the approval periods of 26 substances.
23rd June 2020
EP resolution against extension flumioxazin in plenary meeting
23June
The European Parliament published the draft agenda for the next plenary meeting.
4th June 2020
EU Parliament: another draft resolution against extension of approvals
04June
On the agenda of the meeting of 8 June 2020 of the ENVI Committee appears another objection against the extension of substances.
4th June 2020
Voting results of the SCoPAFF Legislation meeting 18-19 May 2020
The voting results of the SCoPAFF Legislation meeting of 18-19 May 2020 are known.
4th May 2020
Agenda SCoPAFF Legislation meeting 18-19 May published
04May
On 30.04.2020 DG SANTE published the agenda for the SCoPAFF Legislation meeting of 18-19 May 2020.
21st April 2020
ECHA CLH updates
21April
ECHA uploaded information on several substances in its “Registry of Intentions until outcome”, mostly archiving: the uploading of submitted documents from previous consultations.
10th October 2019
EP adopts resolution on the extension of flumioxazin and 33 other substances
10October
On 10.10.2019 the European Parliament has adopted its resolution on Draft Commission Regulation amending Implementing Regulation (EU) 540/2011 as regards the extension of the approval periods...
1st October 2019
EP motion for resolution on approval extension of 34 substances
01October
On 01.10.2019 the European Parliament issued a motion for a resolution on Regulation 2019/707 of 7 May 2019 on the extension of the approval periods of flumioxazine and 33 other substances.